Business Description
MAIA Biotechnology is a Chicago-based company founded in 2018 that develops new cancer treatments aimed at helping patients live longer and better lives. Its primary focus is THIO, a drug currently in clinical trials that works by targeting telomeres in cancer cells that test positive for telomerase, particularly in patients with non-small cell lung cancer.
